Part of the gene mutations that appeared during MDS transformation into AML is represented by those in core hematopoietic transcription factor genes, which include the following genes RUNX1, GATA2, and CEBPA (CCAAT-enhancer binding protein α), and which interfere with the normal process of differentiation [35,66]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.